US2013324416A1PendingUtilityA1

Methods and Compositions for Correlating Genetic Markers with Cardiovascular Disease

60
Assignee: VANCE JEFFERY MPriority: Oct 27, 2004Filed: Jan 16, 2012Published: Dec 5, 2013
Est. expiryOct 27, 2024(expired)· nominal 20-yr term from priority
G16B 20/40G16B 20/20C12Q 2600/172C12Q 1/6883C12Q 2600/118C12Q 2600/106C12Q 2600/156G16B 20/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods of identifying a subject having an increased or decreased risk of developing cardiovascular disease, comprising: a) correlating the presence of one or more genetic markers in chromosome 3q13.31 with an increased or decreased risk of developing cardiovascular disease; and b) detecting the one or more genetic markers of step (a) in the subject, thereby identifying the subject as having an increased or decreased risk of developing cardiovascular disease. Also provided are methods of identifying subjects with cardiovascular disease as having a good or poor prognosis, as well as methods of identifying effective treatment regimens for cardiovascular disease, based on correlation with genetic markers in chromosome 3q13.31.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . A method of identifying a human subject having an increased risk of developing coronary artery disease, comprising detecting in a nucleic acid sample of the subject an A allele at single nucleotide polymorphism rs1676232, wherein detection of said allele identifies the subject as having an increased risk of developing coronary artery disease. 
     
     
         22 . The method of  claim 21 , wherein detecting is carried out by a hybridization reaction. 
     
     
         23 . The method of  claim 22 , wherein the hybridization reaction is carried out with hybridization probes in a microarray. 
     
     
         24 . The method of  claim 21 , wherein detecting is carried out by electrophoresis. 
     
     
         25 . The method of  claim 21 , wherein detecting is carried out by restriction endonuclease digestion analysis. 
     
     
         26 . The method of  claim 21 , wherein detecting is carried out by an amplification reaction. 
     
     
         27 . The method of  claim 26 , wherein the amplification reaction is a polymerase chain reaction.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.